Breast cancer is one of the most common cancers and a leading cause of cancer-related deaths in women. Conducting precise and efficient breast screening is a crucial measure for achieving early diagnosis and treatment of breast cancer. However, multiple bottlenecks in the traditional diagnosis and treatment process cause countless patients to miss the optimal window for early intervention, with anxiety escalating during the prolonged waiting periods. We are dedicated to empowering women to take control of their health through advancements in breast imaging. We strive to create a future where breast cancer can be detected early and treated effectively, thereby improving the lives of millions of women worldwide.
uMammo 870i innovatively integrates Contrast-Enhanced Mammography and Contrast-Enhanced Guided Biopsy, enabling the completion of a uCEM exam in only 7 minutes. It eliminates the long waits for appointment scheduling and test results, relieving women of the anxiety associated with breast screening procedures.
United Imaging innovatively adopts 15° and 40° dual-angle tomosynthesis, enabling personalized diagnosis and treatment protocols tailored to different lesion types. And Tomosynthesis Guided Biopsy can be correspondingly performed under both scan modes. This "on-demand switching" design not only meets the efficiency requirements of large-scale screening but also upholds the medical standards for accurate diagnosis, delivering the optimal chioce for you.
uMammo 870i offers a system patient centricity that makes patients comfortable, relaxed and also easy for technologists to operate that aims to increase patient satisfaction.
FFDM clearly shows an irregular dense palpable mass shadow in the middle of the left posterior-inferior breast with blurred borders and visible lobules.
DBT shows more clearly the glandular hyperplasia with multiple small nodules and a few punctate calcifications
FFDM clearly shows a dense nodular shadow posterior to the posterior aspect of the right nipple, with partially clear borders, visible lobulation and a few punctate calcifications within it.
DBT shows more clearly the calcifications, in greater numbers and with better morphology.
FFDM clearly shows a focal asymmetry of high density in the upper outer anterior part of the right breast and in the middle of the ipsilateral outer posterior part, with poorly defined borders.
DBT shows more clearly a striated low-density shadow within it, extending to the nipple.
DBT clearly shows glandular hyperplasia in both breasts, partly nodular-like and partly bulging towards the skin. It also clearly shows architectural distortion in the posterior aspect of the right breast.
Low-energy image shows an irregular high-density mass shadow in the lateral posterior quadrant of the right breast. The margin is indistinct, with a size of approximately 22×20 mm. The subtraction image demonstrates marked heterogeneous enhancement of the mass, and the enhanced range is consistent with the lesion range on the low-energy image.
Pathological examination result: Invasive carcinoma of the right breast
Stereo Pair clearly pinpoints the target microcalcification. Post-fire Pair clearly shows the position of the needle.
Post-biopsy Pair clearly shows the resected portion of the gland, helping to confirm that the target lesion has been acquired.
